Search Result "lopinavir/ritonavir monotherapy"
Vitamin D Assessment Over 48 Weeks in Treatment-Naive HIV Individuals Starting Lopinavir/Ritonavir Monotherapy
Journal: Current HIV Research
Volume: 19 Issue: 1 Year: 2021 Page: 61-72
Author(s): Rustin D. Crutchley,David M. Jacobs,Joseph Gathe,Carl Mayberry,Nataliya Bulayeva,Kevin P. Rosenblatt,Kevin W. Garey
Fat Tissue Distribution Changes in HIV-Infected Patients Treated with Lopinavir/Ritonavir. Results of the MONARK Trial
Journal: Current HIV Research
Volume: 9 Issue: 1 Year: 2011 Page: 31-39
Author(s): Sami Kolta, Philippe Flandre, Philippe Ngo Van, Isabelle Cohen-Codar, Marc-Antoine Valantin, Claire Pintado, Philippe Morlat, Francois Boue, Richard Rode, Michael Norton, Brygida Knysz, Karine Briot, Christian Roux, Jean-Francois Delfraissy
Protease Inhibitor Monotherapy as Maintenance Regimen in Patients With HIV Infection
Journal: Current HIV Research
Volume: 10 Issue: 8 Year: 2012 Page: 661-672
Author(s): Leonardo Calza,Roberto Manfredi
Differences in Lopinavir Plasma Concentrations Comparing Kaletra® Film Coated Tablets and Soft Gelatine Capsules That Result in Various Lipid Abnormalities
Journal: Drug Metabolism Letters
Volume: 3 Issue: 2 Year: 2009 Page: 67-69
Author(s): Judit Morello, Vincent Soriano, Francisco Blanco, Antonio J. Rubio, Inmaculada Jimenez-Nacher, Sonia Rodriguez-Novoa
Saquinavir/Ritonavir Monotherapy as a New Nucleoside-Sparing Maintenance Strategy in Long-Term Virologically Suppressed HIVInfected Patients
Journal: Current HIV Research
Volume: 8 Issue: 6 Year: 2010 Page: 467-470
Author(s): Patricia Echeverria, Pere Domingo, Mar Gutierrez, Mateo Gracia, Monse Fuster, Jose Molto, Jordi Puig, Nuria Perez-Alvarez, Bonaventura Clotet, Eugenia Negredo
Inhibitors of HIV-1 Protease: Current State of the Art 10 Years After their Introduction. From Antiretroviral Drugs to Antifungal, Antibacterial and Antitumor Agents Based on Aspartic Protease Inhibitors
Journal: Current Medicinal Chemistry
Volume: 14 Issue: 2 Year: 2007 Page: 2734-2748
Author(s): Antonio Mastrolorenzo, Stefano Rusconi, Andrea Scozzafava, Giuseppe Barbaro, Claudiu T. Supuran
Pharmacological Strategies for COVID-19 - A Review of the Most Promising Repurposed Antiviral Drugs
Journal: Infectious Disorders - Drug Targets
Volume: 21 Issue: 7 Year: 2021 Page: 3-11
Author(s): Deepti Chopra,Jaspreet K Boparai,Bharti Bhandari,Anurag Srivastava,Rakesh Gupta
Current Treatment Methods for Coronavirus Disease-19
Ebook: COVID-19: Diagnosis and Management-Part II
Volume: 1 Year: 2021
Author(s): Nirmal Singh,Amteshwar S. Jaggi,Dhandeep Singh,Pankaj Bhatia,Sonal,Kuldeep Kumar
Doi: 10.2174/9781681088051121010005
A Recent Update on the Clinical Trials and Effectiveness of Drugs Used inCOVID-19, MERS and SARS Coronaviruses
Journal: Anti-Infective Agents
Volume: 20 Issue: 2 Year: 2022 Page: 8-33
Author(s): Seyed Sajad Hosseini Balef,Zohreh Karimi,Ala Azari,Seyed Sadeq Sadraie,Parisa Hasanjani,Yasaman Sadeghi,Samin Ahmadi,Fatemeh Qorbannejad,Ali Farmoudeh,Hamid Irannejad
QT Interval Monitoring and Drugs Management During COVID-19 Pandemic
Journal: Current Clinical Pharmacology
Volume: 15 Issue: 0 Year: 2020 Page: 1-13
Author(s): Alessio Gasperetti,Marco Schiavone,Claudio Tondo,Gianfranco Mitacchione,Maurizio Viecca,Massimo Galli,Piercarlo Sarzi-Puttini,Giovanni Battista Forleo